Literature DB >> 28066778

Genome editing in human pluripotent stem cells: a systematic approach unrevealing pancreas development and disease.

Elena Garreta1, Andres Marco1, Juan Carlos Izpisua Belmonte2, Nuria Montserrat3.   

Abstract

Entities:  

Year:  2016        PMID： 28066778      PMCID： PMC5182204          DOI： 10.21037/sci.2016.10.11

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN： 2306-9759


× No keyword cloud information.
  23 in total

1.  Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes

Authors: 
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 2.  Diseases in a dish: modeling human genetic disorders using induced pluripotent cells.

Authors:  Gustavo Tiscornia; Erica Lorenzo Vivas; Juan Carlos Izpisúa Belmonte
Journal:  Nat Med       Date:  2011-12       Impact factor: 53.440

3.  Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells.

Authors:  Alireza Rezania; Jennifer E Bruin; Payal Arora; Allison Rubin; Irina Batushansky; Ali Asadi; Shannon O'Dwyer; Nina Quiskamp; Majid Mojibian; Tobias Albrecht; Yu Hsuan Carol Yang; James D Johnson; Timothy J Kieffer
Journal:  Nat Biotechnol       Date:  2014-09-11       Impact factor: 54.908

4.  Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus.

Authors:  E H Hani; D A Stoffers; J C Chèvre; E Durand; V Stanojevic; C Dina; J F Habener; P Froguel
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells.

Authors:  Kevin A D'Amour; Anne G Bang; Susan Eliazer; Olivia G Kelly; Alan D Agulnick; Nora G Smart; Mark A Moorman; Evert Kroon; Melissa K Carpenter; Emmanuel E Baetge
Journal:  Nat Biotechnol       Date:  2006-10-19       Impact factor: 54.908

6.  Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism.

Authors:  Valérie Senée; Claude Chelala; Sabine Duchatelet; Daorong Feng; Hervé Blanc; Jack-Christophe Cossec; Céline Charon; Marc Nicolino; Pascal Boileau; Douglas R Cavener; Pierre Bougnères; Doris Taha; Cécile Julier
Journal:  Nat Genet       Date:  2006-05-21       Impact factor: 38.330

7.  Rfx6 directs islet formation and insulin production in mice and humans.

Authors:  Stuart B Smith; Hui-Qi Qu; Nadine Taleb; Nina Y Kishimoto; David W Scheel; Yang Lu; Ann-Marie Patch; Rosemary Grabs; Juehu Wang; Francis C Lynn; Takeshi Miyatsuka; John Mitchell; Rina Seerke; Julie Désir; Serge Vanden Eijnden; Marc Abramowicz; Nadine Kacet; Jacques Weill; Marie-Eve Renard; Mattia Gentile; Inger Hansen; Ken Dewar; Andrew T Hattersley; Rennian Wang; Maria E Wilson; Jeffrey D Johnson; Constantin Polychronakos; Michael S German
Journal:  Nature       Date:  2010-02-11       Impact factor: 49.962

8.  Neonatal diabetes, gallbladder agenesis, duodenal atresia, and intestinal malrotation caused by a novel homozygous mutation in RFX6.

Authors:  Jennifer P Concepcion; Christina S Reh; Mark Daniels; Xiaoming Liu; Veronica P Paz; Honggang Ye; Heather M Highland; Craig L Hanis; Siri Atma W Greeley
Journal:  Pediatr Diabetes       Date:  2013-08-05       Impact factor: 4.866

Review 9.  Genetic and epigenetic variations in iPSCs: potential causes and implications for application.

Authors:  Gaoyang Liang; Yi Zhang
Journal:  Cell Stem Cell       Date:  2013-08-01       Impact factor: 24.633

10.  Permanent Neonatal Diabetes and Enteric Anendocrinosis Associated With Biallelic Mutations in NEUROG3.

Authors:  Oscar Rubio-Cabezas; Jan N Jensen; Maria I Hodgson; Ethel Codner; Sian Ellard; Palle Serup; Andrew T Hattersley
Journal:  Diabetes       Date:  2011-03-04       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.